サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/12/01 | 1,457 | 1,480 | 1,436 | 1,450 | -15 | -1% | 197,200 |
| 2016/11/30 | 1,420 | 1,478 | 1,416 | 1,465 | +45 | +3.2% | 295,700 |
| 2016/11/29 | 1,388 | 1,443 | 1,386 | 1,420 | +22 | +1.6% | 128,700 |
| 2016/11/28 | 1,405 | 1,413 | 1,384 | 1,398 | +1 | +0.1% | 91,600 |
| 2016/11/25 | 1,415 | 1,415 | 1,381 | 1,397 | -19 | -1.3% | 142,900 |
| 2016/11/24 | 1,430 | 1,434 | 1,400 | 1,416 | +2 | +0.1% | 163,100 |
| 2016/11/22 | 1,400 | 1,426 | 1,360 | 1,414 | -2 | -0.1% | 411,000 |
| 2016/11/21 | 1,473 | 1,491 | 1,413 | 1,416 | -83 | -5.5% | 447,300 |
| 2016/11/18 | 1,525 | 1,533 | 1,487 | 1,499 | -19 | -1.3% | 221,100 |
| 2016/11/17 | 1,473 | 1,518 | 1,462 | 1,518 | +38 | +2.6% | 259,100 |
| 2016/11/16 | 1,458 | 1,485 | 1,448 | 1,480 | +11 | +0.7% | 196,200 |
| 2016/11/15 | 1,385 | 1,469 | 1,375 | 1,469 | +85 | +6.1% | 345,800 |
| 2016/11/14 | 1,377 | 1,408 | 1,372 | 1,384 | +9 | +0.7% | 90,400 |
| 2016/11/11 | 1,412 | 1,413 | 1,362 | 1,375 | -18 | -1.3% | 95,500 |
| 2016/11/10 | 1,367 | 1,420 | 1,362 | 1,393 | +86 | +6.6% | 235,700 |
| 2016/11/09 | 1,369 | 1,385 | 1,235 | 1,307 | -63 | -4.6% | 414,400 |
| 2016/11/08 | 1,400 | 1,403 | 1,357 | 1,370 | -25 | -1.8% | 107,500 |
| 2016/11/07 | 1,344 | 1,397 | 1,329 | 1,395 | +21 | +1.5% | 307,300 |
| 2016/11/04 | 1,310 | 1,378 | 1,301 | 1,374 | +38 | +2.8% | 297,900 |
| 2016/11/02 | 1,336 | 1,363 | 1,300 | 1,336 | -16 | -1.2% | 305,400 |
| 2016/11/01 | 1,399 | 1,402 | 1,348 | 1,352 | -57 | -4% | 327,100 |
| 2016/10/31 | 1,417 | 1,422 | 1,397 | 1,409 | -9 | -0.6% | 126,600 |
| 2016/10/28 | 1,444 | 1,461 | 1,394 | 1,418 | -22 | -1.5% | 173,300 |
| 2016/10/27 | 1,450 | 1,467 | 1,430 | 1,440 | +30 | +2.1% | 197,600 |
| 2016/10/26 | 1,392 | 1,423 | 1,392 | 1,410 | +11 | +0.8% | 106,500 |
| 2016/10/25 | 1,440 | 1,442 | 1,395 | 1,399 | -48 | -3.3% | 196,100 |
| 2016/10/24 | 1,473 | 1,489 | 1,436 | 1,447 | -33 | -2.2% | 110,700 |
| 2016/10/21 | 1,449 | 1,492 | 1,441 | 1,480 | +46 | +3.2% | 287,500 |
| 2016/10/20 | 1,425 | 1,438 | 1,416 | 1,434 | +9 | +0.6% | 81,900 |
| 2016/10/19 | 1,415 | 1,442 | 1,412 | 1,425 | -1 | -0.1% | 74,300 |
| 2016/10/18 | 1,407 | 1,436 | 1,405 | 1,426 | +19 | +1.4% | 124,100 |
| 2016/10/17 | 1,416 | 1,430 | 1,402 | 1,407 | -20 | -1.4% | 85,700 |
| 2016/10/14 | 1,429 | 1,444 | 1,405 | 1,427 | +10 | +0.7% | 130,100 |
| 2016/10/13 | 1,429 | 1,433 | 1,404 | 1,417 | -1 | -0.1% | 84,500 |
| 2016/10/12 | 1,465 | 1,466 | 1,390 | 1,418 | -34 | -2.3% | 194,300 |
| 2016/10/11 | 1,465 | 1,502 | 1,443 | 1,452 | -4 | -0.3% | 186,900 |
| 2016/10/07 | 1,434 | 1,461 | 1,424 | 1,456 | +17 | +1.2% | 132,900 |
| 2016/10/06 | 1,457 | 1,466 | 1,435 | 1,439 | -27 | -1.8% | 120,900 |
| 2016/10/05 | 1,438 | 1,470 | 1,430 | 1,466 | +26 | +1.8% | 160,500 |
| 2016/10/04 | 1,512 | 1,520 | 1,435 | 1,440 | -68 | -4.5% | 305,800 |
| 2016/10/03 | 1,502 | 1,540 | 1,491 | 1,508 | +18 | +1.2% | 200,800 |
| 2016/09/30 | 1,501 | 1,510 | 1,470 | 1,490 | -45 | -2.9% | 283,400 |
| 2016/09/29 | 1,580 | 1,580 | 1,515 | 1,535 | -45 | -2.8% | 272,800 |
| 2016/09/28 | 1,577 | 1,585 | 1,550 | 1,580 | -5 | -0.3% | 231,200 |
| 2016/09/27 | 1,589 | 1,601 | 1,465 | 1,585 | -10 | -0.6% | 768,500 |
| 2016/09/26 | 1,487 | 1,610 | 1,480 | 1,595 | +108 | +7.3% | 830,400 |
| 2016/09/23 | 1,452 | 1,502 | 1,419 | 1,487 | +120 | +8.8% | 716,500 |
| 2016/09/21 | 1,361 | 1,372 | 1,346 | 1,367 | +25 | +1.9% | 102,400 |
| 2016/09/20 | 1,379 | 1,399 | 1,341 | 1,342 | -30 | -2.2% | 179,500 |
| 2016/09/16 | 1,337 | 1,372 | 1,319 | 1,372 | +50 | +3.8% | 137,500 |
1951～
2000
件表示中 / 2354件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| タウンズ | 56,300円 | +4.6% | +6.1% | 4.97% | 9.46倍 | 4.17倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症得意 |
市場注目の銘柄
チャート関連のコラム
